Mesenchymal Stem Cells is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Mesenchymal stem cells (MSCs), also known as mesenchymal stromal cells, are multipotent stromal cells capable of self-renewal and differentiation into various cell types including osteoblasts, chondrocytes, adipocytes, and myocytes. In the context of neurodegeneration, MSCs have attracted significant interest for their potential therapeutic applications due to their immunomodulatory properties, ability to secrete neurotrophic factors, and potential for neural differentiation. [@supsup2008]
Mesenchymal Stem Cells is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Mesenchymal stem cells (MSCs), also known as mesenchymal stromal cells, are multipotent stromal cells capable of self-renewal and differentiation into various cell types including osteoblasts, chondrocytes, adipocytes, and myocytes. In the context of neurodegeneration, MSCs have attracted significant interest for their potential therapeutic applications due to their immunomodulatory properties, ability to secrete neurotrophic factors, and potential for neural differentiation. [@supsup2008]
Dopaminergic differentiation: Potential to replace lost neurons
Neuroprotection: Trophic support for remaining neurons
Immunomodulation: Reduce neuroinflammation
Alpha-synuclein: May reduce aggregation
Clinical trials: Several Phase 1/2 trials completed
Alzheimer's Disease
Amyloid modulation: May enhance clearance
Tau pathology: Potential effects on phosphorylation
Neuroinflammation: Shift microglia to M2
Synaptic support: BDNF secretion
Cognitive improvement: Reported in preclinical models
Amyotrophic Lateral Sclerosis
Motor neuron support: Neurotrophic factors
Glutamate regulation: Reduce excitotoxicity
Immunomodulation: Reduce inflammatory response
Clinical trials: Mixed results to date
Stroke and Traumatic Brain Injury
Neurorestoration: Support regeneration
Angiogenesis: Promote blood vessel formation
Anti-scarring: Modulate glial scar
Mechanisms of Action
Cell Replacement
Direct differentiation: Become neural cells
Fusion: With host neurons
Transdifferentiation: Direct conversion
Paracrine Signaling
Exosome secretion:Nano-sized vesicles
Trophic support: Growth factors
Anti-apoptotic effects: Reduce cell death
Immunomodulation
Systemic effects: Modulate peripheral immunity
Central effects: Microglia modulation
Anti-inflammatory: Reduce cytokine release
Clinical Considerations
Advantages
Autologous: Patient's own cells (reduced rejection)
Allogeneic: Off-the-shelf options available
Accessible: Easy to obtain and expand
Safety: Well-tolerated in clinical trials
Non-tumorigenic: Low transformation risk
Challenges
Heterogeneity: Variable preparations
Dosing: Optimal cell number unclear
Delivery: Route of administration
Survival: Engraftment in CNS
Differentiation: Efficiency in vivo
Delivery Routes
Intravenous: Systemic administration
Intrathecal: Cerebrospinal fluid
Intracerebral: Direct to brain
Intranasal: Non-invasive option
Background
The study of Mesenchymal Stem Cells has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data